saplin

SBI HEALTHCARE OPPORTUNITIES FUND

SBI HEALTHCARE OPPORTUNITIES FUND (Direct, Growth): saplin Score 8.7/10 (Strong) among 14 Sectoral/Thematic funds. 3Y return 25.2% a year vs 21.9% category median, expense ratio 0.99%. Better downside protection than most peers, with nothing standing out as a weakness. NAV ₹625.44 on 11 Nov 2026.

Loading the full analysis…

Questions about SBI HEALTHCARE OPPORTUNITIES FUND

What is the expense ratio of SBI HEALTHCARE OPPORTUNITIES FUND?

The Direct plan's total expense ratio is 0.99% a year, against a median of 1.04% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages SBI HEALTHCARE OPPORTUNITIES FUND?

Tanmaya Desai (since 27 Jun 2011).

What are the top holdings of SBI HEALTHCARE OPPORTUNITIES FUND?

Sun Pharmaceutical Industries 10.55%, Divi's Laboratories 8.38%, Max Healthcare Institute 4.96%, Acutaas Chemicals 4.95%, Apollo Hospitals Enterprise 4.87% of the portfolio, as of 31 Oct 2026.

What returns has SBI HEALTHCARE OPPORTUNITIES FUND given?

1 year: 26.2% (category median 21.9%); 3 years: 25.2% a year (category median 21.9%); 5 years: 20.6% a year (category median 16.8%). Past returns do not predict future ones.

How big is SBI HEALTHCARE OPPORTUNITIES FUND?

About ₹5,565 cr (AMFI's average for the latest quarter).

How does SBI HEALTHCARE OPPORTUNITIES FUND score?

8.7 out of 10 (Strong) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on SBI Healthcare Opportunities